BDBM476464 (2S)-1-[(2R)-2-[(1- methylethyl)amino]-2-{trans-4-[(1- methylethyl)amino]cyclohexyl}acetyl]- 4-[(4S,5S)-4-methyl-5-phenyl-4,5- dihydro-1,3-oxazol-2-yl]-N-(thiophen- 2-ylmethyl)piperazine-2-carboxamide::US10875851, Example 120

SMILES CC(C)N[C@@H](C(=O)N1CCN(C2=N[C@@H](C)[C@H](c3ccccc3)O2)C[C@H]1C(=O)NCc1cccs1)[C@H]1CC[C@H](NC(C)C)CC1

InChI Key InChIKey=HGBCWGOUPAKLBU-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 476464   

TargetCoagulation factor XII(Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 476464BDBM476464((2S)-1-[(2R)-2-[(1- methylethyl)amino]-2-{trans-4-...)
Affinity DataIC50: 5.60nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of Coagulation Factor XIIa can be determined using a relevant purified serin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
US Patent